Sprycel 10 mg / mL powder for oral suspension

Licence status
Authorised: 02/07/2018
Active substances
Dasatinib
Dosage Form
Powder for oral suspension
Licence number
EU/1/06/363/016
Licence holder
Bristol-Myers Squibb Pharma EEIG

Product documents

Licence information

ATC code
L01XE Protein kinase inhibitors, L01XE06 dasatinib
Legal supply status
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Conditions of Licence
Medicinal product subject to special and restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).
Marketing availability
Unknown
Advertising conditions
Advertising to healthcare professionals only
Licence issued
02/07/2018